Study on effect of electroacupuncture at upper limb acupoints on the corticospinal excitability of erector spinae

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300072907

Enrollment

Unknown

Registered

2023-06-28

Start date

2022-06-04

Completion date

Unknown

Last updated

2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

test 1:group 1:Subjects received 30min EA stimulus at LI4

test 1:group 2:Subjects received 30min EA stimulus at LU6

test 1:group 3:Subjects received 30min sham-EA stimulus at SI3

test2:group 1:Subjects received 30min EA stimulus at LI4 and 20min inhibition of dorsal premotor cortex by rTMS(1Hz)

test2:group 1:Subjects received 30min EA stimulus at LU6 and 20min inhibition of dorsal premotor cortex by rTMS(1Hz)

Eligibility

Sex/Gender

All

Age

19 Years to 29 Years

Inclusion criteria

Inclusion criteria: 1. Meet the WHO definition of 'health'; 2. Right handed subjects, aged from 18 to 35; 3. Patients without neurological, mental and motor diseases in the past; 4. Subjects who have no history of acupuncture sickness; 5. Subjects who have not received any peripheral stimulation (such as acupuncture, peripheral electrical stimulation, etc.) or central stimulation (such as rTMS, tDCS, etc.) in the past 3 months; 6. Subjects who voluntarily participated in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with mental system diseases, such as schizophrenia, anxiety disorder, personality disorder, etc; 2. Patients with nervous system diseases, such as brain trauma, posterior cranial fossa disease, spasm, trigeminal neuralgia, Jackson epilepsy, spasm after facial paralysis, blepharospasm, cognitive impairment, speech disorder and dementia, etc; 3. Patients with history of severe hypertension, diabetes, malignant tumor, and other diseases of heart, liver, kidney and other organs; 4. Patients with metal residues (including denture, pacemaker, nerve stimulator, medical pump, etc.); 5. Subjects who were afraid of TMS and could not be stimulated by TMS for other reasons; 6. Subjects who are afraid of acupuncture, or infection of the acupoint and its surrounding skin; Or have coagulopathy; 7. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
Motor evoked potential(amplitude);	—

Secondary

Measure	Time frame
Motor evoked potential(latent period);Motor Threshold;	—

Countries

China

Contacts

Public ContactJianhua Liu

Department of Acupuncture and Moxibustion, Guangdong Provincail Hospital of Traditional Chinese Medicine

jyhf08@sina.com+86 137 2988 9452

Outcome results